Molina Healthcare (NYSE:MOH - Free Report) had its target price boosted by Mizuho from $376.00 to $400.00 in a research note released on Wednesday morning,Benzinga reports. The brokerage currently has an outperform rating on the stock.
MOH has been the subject of a number of other reports. StockNews.com cut Molina Healthcare from a "buy" rating to a "hold" rating in a report on Thursday, April 3rd. Wells Fargo & Company raised Molina Healthcare from an "equal weight" rating to an "overweight" rating and upped their price objective for the stock from $295.00 to $372.00 in a report on Wednesday, March 5th. JPMorgan Chase & Co. reissued a "neutral" rating and issued a $350.00 target price (down from $378.00) on shares of Molina Healthcare in a research note on Tuesday, December 17th. Truist Financial decreased their price target on Molina Healthcare from $370.00 to $340.00 and set a "buy" rating on the stock in a report on Wednesday, February 19th. Finally, UBS Group cut their target price on shares of Molina Healthcare from $374.00 to $325.00 and set a "neutral" rating on the stock in a research report on Friday, February 7th. Seven equities research analysts have rated the stock with a hold rating, seven have issued a buy rating and one has given a strong buy rating to the company's stock. According to data from MarketBeat.com, the stock currently has an average rating of "Moderate Buy" and an average price target of $355.75.
View Our Latest Research Report on Molina Healthcare
Molina Healthcare Price Performance
Shares of MOH stock traded up $1.80 during trading hours on Wednesday, hitting $346.80. The company had a trading volume of 150,173 shares, compared to its average volume of 652,702. The firm's fifty day moving average is $310.39 and its 200 day moving average is $307.97. Molina Healthcare has a 12 month low of $262.32 and a 12 month high of $373.22. The firm has a market capitalization of $18.97 billion, a price-to-earnings ratio of 16.98, a PEG ratio of 1.06 and a beta of 0.70. The company has a debt-to-equity ratio of 0.69, a quick ratio of 1.62 and a current ratio of 1.62.
Molina Healthcare (NYSE:MOH - Get Free Report) last posted its earnings results on Wednesday, February 5th. The company reported $5.05 earnings per share for the quarter, missing the consensus estimate of $5.74 by ($0.69). Molina Healthcare had a return on equity of 28.13% and a net margin of 2.90%. On average, sell-side analysts predict that Molina Healthcare will post 24.4 EPS for the current fiscal year.
Insiders Place Their Bets
In other news, Director Steven J. Orlando sold 1,000 shares of the company's stock in a transaction that occurred on Monday, March 3rd. The stock was sold at an average price of $301.33, for a total transaction of $301,330.00. Following the sale, the director now owns 17,375 shares in the company, valued at $5,235,608.75. This represents a 5.44 % decrease in their position. The sale was disclosed in a document filed with the SEC, which is available at this link. Insiders own 1.10% of the company's stock.
Institutional Inflows and Outflows
Several institutional investors have recently modified their holdings of MOH. Wellington Management Group LLP increased its position in Molina Healthcare by 7.4% during the fourth quarter. Wellington Management Group LLP now owns 2,632,232 shares of the company's stock worth $766,111,000 after buying an additional 181,073 shares during the last quarter. FMR LLC increased its holdings in shares of Molina Healthcare by 31.1% during the 4th quarter. FMR LLC now owns 1,801,113 shares of the company's stock worth $524,214,000 after acquiring an additional 427,276 shares during the last quarter. Geode Capital Management LLC raised its stake in Molina Healthcare by 2.5% in the 4th quarter. Geode Capital Management LLC now owns 1,436,909 shares of the company's stock valued at $417,144,000 after acquiring an additional 34,992 shares during the period. Invesco Ltd. lifted its holdings in Molina Healthcare by 28.5% during the 4th quarter. Invesco Ltd. now owns 1,327,021 shares of the company's stock valued at $386,229,000 after purchasing an additional 294,180 shares during the last quarter. Finally, Dimensional Fund Advisors LP boosted its position in Molina Healthcare by 15.3% during the fourth quarter. Dimensional Fund Advisors LP now owns 688,245 shares of the company's stock worth $200,307,000 after purchasing an additional 91,229 shares during the period. 98.50% of the stock is currently owned by institutional investors and hedge funds.
About Molina Healthcare
(
Get Free Report)
Molina Healthcare, Inc provides managed healthcare services to low-income families and individuals under the Medicaid and Medicare programs and through the state insurance marketplaces. It operates in four segments: Medicaid, Medicare, Marketplace, and Other. The company served in across 19 states. The company was founded in 1980 and is headquartered in Long Beach, California.
Further Reading

Before you consider Molina Healthcare, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Molina Healthcare wasn't on the list.
While Molina Healthcare currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Which stocks are hedge funds and endowments buying in today's market? Enter your email address and we'll send you MarketBeat's list of thirteen stocks that institutional investors are buying now.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.